"Regardless of the insurance and of their access to prescription treatment, there are considerable risks associated with being a member of a racial and ethnic community, and increased risk of ...

Use of digital measurement tools to track individual adherence to treatment helped avoid raising doses or adding medications and improved adherence in patients with uncontrolled asthma, the INCA Sun ...

Lemanske RF, Mauger DT, Sorkness CA, et al, for the Childhood Asthma Research and Education (CARE) Network of the National, Heart, Lung, and Blood Institute. This study evaluated whether any of 3 ...

Please provide your email address to receive an email when new articles are posted on . Less than 15% of PCPs reported managing patients with uncontrolled asthma at least once a week. More PCPs ...

Higher baseline blood eosinophil count was linked to improvement in asthma exacerbations and overall better outcomes seen with biologic therapies. Biologics’ efficacy in patients with severe, ...

Nearly 90% of adults had maintenance OCS dose of 5mg/day or less after 52 weeks of treatment. HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, ...

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

Asthma diagram, lungs A post hoc analysis of the QUEST trial assessed clinical remission in patients with moderate-to-severe asthma after 24 and 52 weeks of dupilumab treatment. The following article ...

Patients with uncontrolled asthma had reduced symptoms and exacerbations with tezepelumab, according to a new study. Tezepelumab was effective in improving forced expiratory volume per 1 second (FEV 1 ...

NEW YORK (Reuters Health) - In a recent U.S. survey of asthma patients, more than half reported that their disease is uncontrolled and that they have never received an asthma action plan, according to ...

A new Phase 2 clinical study is now enrolling adults with moderate to severe asthma to evaluate the safety and efficacy of Brenipatide, an investigational, once-weekly subcutaneous injection designed ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – Did you know 1 in 13 people in the U.S. live with asthma?